Hereditary hemochromatosis

Clinica Chimica Acta

Volumn 245, Issue 2, 1996, Pages 139-200

  Witte, David L ^a,b   Crosby, William H ^b   Edwards, Corwin Q ^b   Fairbanks, Virgil F ^b   Mitros, Frank A ^b  

^a Laboratory Control Ltd   (United States)

^b Molecular Pathology Division   (United States)

Author keywords

Case finding; Ferritin; Hemochromatosis; Phlebotomy; Transferrin

Indexed keywords

AMINOTRANSFERASE; GONADOTROPIN; IRON; LIVER ENZYME; THYROTROPIN; TRANSFERRIN;

ALCOHOLISM; CHRONIC HEPATITIS; DEATH; DIABETES MELLITUS; DIAGNOSIS; ECONOMICS; ETHNOLOGY; HEMOCHROMATOSIS; HISTOPATHOLOGY; HLA TYPING; HYPERGLYCEMIA; IMPOTENCE; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; MORBIDITY; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; ARTICLE; FEMALE; GENETICS; HUMAN; MALE; PRACTICE GUIDELINE;

ARANEAE;

FEMALE; HEMOCHROMATOSIS; HUMANS; MALE;

EID: 0030604479     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(95)06212-2     Document Type: Article

References (202)

1. Saddi R, Feingold J. Idiopathic haemochromatosis: an autosomal recessive disease. Clin Genet 1974;5:234-241.
2. Simon M et al. Hemochromatose idiopathique: maladie associee a l'antigene tissulaire HL-A3? Nouvelle Presse Medicale 1975;4:1432.
3. Simon M et al. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1021.
4. Cartwright GE et al. Inheritance of hemochromatosis: linkage to HLA. Trans Assoc Am Physicians 1978;91:273-281.
5. Lipinski M, Hors J, Saleun JP et al. Idiopathic hemochromatosis: linkage with HLA. Tissue Antigens 1978;11:471-474.
6. Kravitz K, Skolnick M, Edwards CQ et al. Pedigree analysis of the linkage between HLA and hemochromatosis. In: Morton NE, Chung CS, eds. Genetic epidemiology. New York: Academic Press, 1978:241-246.
7. Edwards CQ, Skolnick MH, Kushner JP. Hereditary hemochromatosis: contributions of genetic analyses. Prog Hematol 1981;12:43-71.
8. Kravitz K, Skolnick M, Cannings C et al. Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet 1979;31:601-619.
9. Cartwright GE, Edward CQ, Kravitz K et al. Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J Med 1979;301:175-179.
10. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Genetic mapping of the hemochromatosis locus on chromosome six. Hum Immunol 1980;1:19-22.
11. Edwards CQ et al. Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A. Am J Hum Genet 1986;38:805-811.
12. David V et al. DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family. Hum Genet 1986;74:113-120.
13. Edwards CQ, Griffen LM, Kushner JP. Southern Blood Club Symposium: an update on selected aspects of hemochromatosis. Am J Med Sci 1990;300:245-250.
14. Edwards CQ, Griffen LM, Kushner JP. Disorders of excess iron. Hosp Pract 1991;26(3):30-36.
15. Powell LW et al. Is all genetic (hereditary) hemochromatosis HLA-associated? Ann NY Acad Sci 1988;526:23-33.
16. Case Records of the Massachusetts General Hospital. N Engl J Med 1958;258:652-661.
17. Case Records of the Massachusetts General Hospital. N Engl J Med 1952;247:992-995.
18. Fairbanks VF et al. Clinical disorders of iron metabolism. 2nd ed. New York: Grune and Stratton, 1971.
19. Henniger GR et al. Hemochromatosis caused by excessive vitamin iron intake. Am J Pathol 1979;96:611-624.
20. Johnson BF. Hemochromatosis resulting from prolonged oral iron therapy. N Engl J Med 1968;278:1100-1101.
21. Morningstar WA. Exogenous hemochromatosis: a report of three cases. Arch Pathol 1955;59:355.
22. Pletcher WD et al. Hemochromatosis following prolonged iron therapy in a patient with hereditary nonspherocytic hemolytic anaemia. Am J Med Sci 1963;246:27.
23. Turnberg LA. Excessive oral iron therapy causing haemochromatosis. Br Med J 1965;1:1360.
24. Wallerstein RO, Robbins SL. Hemochromatosis after prolonged oral iron therapy in a patient with chronic hemolytic anemia. Am J Med 1953;14:256-260.
25. Wheby MS. Medicinal iron-induced hepatic cirrhosis: reversal by phlebotomy: studies on pathogenesis. Trans Am Clin Climatol Assoc 1977;89:100.
26. Green P, Eviatar JM, Sirota P, Avidor I. Secondary hemochromatosis due to prolonged iron ingestion. Isr J Med Sci 1989;25:199-201.
27. de Braekeleer M, St.-Pierre C, Vigneault A, Simard H, de Medicis E. Hemochromatosis and pyruvate kinase deficiency. Ann Hematol 1991;62:188-189.
28. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol 1991;38:150-152.
29. Dalhoj J, Kiaer H, Wiggers P, Grady RW, Jones RL, Knisely AS. Iron storage disease in parents and sibs of infants with neonatal hemochromatosis: 30-year follow-up. Am J Med Genet 1990;37:342-345.
30. Knisely AS. Neonatal hemochromatosis. Adv Pediatr 199;38:383-403.
31. Gordeuk V et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992;326:95-100.
32. Bacon BR. Causes of iron overload. N Engl J Med 1992;326:126-127.
33. Edwards CQ et al. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med 1980;93:519-525.
34. Edwards CQ et al. Hereditary haemochromatosis. Clin Haematol 1982;11:411-435.
35. Edwards CQ et al. Prevalence of hemochromatosis among 11 065 presumably healthy blood donors. N Engl J Med 1988;318:1355-1362.
36. Edwards CQ, Griffen LM, Kushner JP. Comparison of stainable liver iron between symptomatic and asymptomatic hemochromatosis homozygotes and their homozygous relatives. Am J Med Sci 1991;301:44-46.
37. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991;90:445-449.
38. Haddy TB, Castro OL, Rana SR. Hereditary hemochromatosis in children, adolescents, and young adults. Am J Pediatr Hematol Oncol 1988;10:23-34.
39. Perkins KW, Mclnnes IWS, Blackburn CRB, Beal RW. Idiopathic haemochromatosis in children: report of a family. Am J Med 1965;39:118-126.
40. Charlton RW, Abrahams C, Bothwell TH. Idiopathic hemochromatosis in young subjects. Arch Pathol 1967;83:132-140.
41. Kaltwasser JP, Schalk KP, Werner E. Juvenile hemochromatosis. In: Weintraub LR, Edwards CQ, Krikker M, eds. Hemochromatosis: Proceedings of the First International Conference, New York City. Ann NY Acad Sci 1988;526:339-341.
42. Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976;45:611-623.
43. Niederau C et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-1262.
44. Adams PC, Speechley M, Kertesz AE. Long-term survival in hereditary hemochromatosis. Gastroenterology 1991;101:368-372.
45. Olsson KS, Ritter B, Lundin PM. Liver affection in iron overload studied with serum ferritin and serum aminotransferases. Acta Med Scand 1985;217:79-84.
46. Kelly TM et al. Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med 1984;101:629-632.
47. Siemens LJ et al. Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab 1987;65:585.
48. Lufkin EG et al. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis. Mayo Clin Proc 1987;62:473.
49. Dymock IW et al. Arthropathy of haemochromatosis: clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis 1970;29:469-476.
50. Schumacher HR et al. The arthropathy of hemochromatosis: recent studies. Ann NY Acad Sci 1988;526:224-233.
51. Knauer CM, Gamble CN, Monroe LS. The reversal of hemochromatotic cirrhosis by multiple phlebotomies: report of a case. Gastroenterology 1965;49:667-671.
52. Weintraub LR, Conrad ME, Crosby WH. The treatment of hemochromatosis by phlebotomy. Med Clin North Am 1966;0:1579-1589.
53. Powell LW, Kerr JFR. Reversal of 'cirrhosis' in idiopathic haemochromatosis following long-term intensive venesection therapy. Australasian Ann Med 1970;19:54-57.
54. Chopra S, Ibrahim R et al. Reversal of cirrhosis in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 1988;95:1399-1402.
55. Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis: study of 71 patients treated with venesection therapy. Appl Pathol 1988;6:128-138.
56. Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut 1988;29:1603-1606.
57. Amman RW, Muller E, Bansky J, Schuler G, Hacki WH. High incidence of extrahepatic carcinomas in idiopathic hemochromatosis. Scand J Gastroenterol 1980;15:733-736.
58. Milder MS et al. Idiopathic hemochromatosis, an interim report. Medicine 1980;59: 34-49.
59. Bradbear RA, Bain C, Siskind V et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst 1985;75:81-84.
60. Edwards CQ et al. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med 1989;226:373-379.
61. Meyer TE, Ballot D, Bothwell TH et al. The HLA linked iron loading gene in an Afrikaner population. J Med Genet 1987;24:348-356.
62. Lindmark B, Eriksson S. Regional differences in the idiopathic hemochromatosis gene frequency in Sweden. Acta Med Scand 1985;218:299-304.
63. Olsson KS, Ritter B, Rosen U, Heedman PA, Staugard F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145-150.
64. Hallberg L, Bjorn-Rasmussen E, Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med 1989;225:249-255.
65. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic expression of hemochromatosis in Canadians. Clin Invest Med 1983;6:171-179.
66. Baur MP et al. In: Terasaki PI, ed. Histocompatibility testing. UCLA Tissue Registry, 1980:955.
67. Reed TE. Caucasian genes in American Negros. Science 1969;165:762-768.
68. Li CC. First Course in Population Genetics. Pacific Grove, Calif.: Boxwood Press, 540-542.
69. Reed TE. Issues in estimating Caucasian admixture in American Blacks. Am J Hum Genet 1992;51:678-679.
70. Hsieh C-L, Sutton HE. Mitochondrial and nuclear variants in a U.S. Black population: origins of a hybrid population. Ann Hum Genet 1992;56:105-112.
71. Chakraborty R, Kamboh MI, Nwankwo M, Ferrell RE. Caucasian genes in American Blacks: new data. Am J Hum Genet 1992;50:145-155.
72. Krainin P, Kahn BS. Hemochromatosis: report of a case in a Negro; discussion of iron metabolism. Ann Intern Med 1950;33:452-462.
73. Wurapa et al. Abstract. Blood 1993;82(1):95.
74. Barton et al. Iron over load disease symposium. Rochester, N.Y.: May 1994.
75. Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
76. Panajotopoulos N, Piperno A, Conte D, Mandelli C, Cesane M, Mercuriali F, Fiorelli, Bianchi PA, Fargion S. HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives. Tissue Antigens 1989;33:431-436.
77. Finch SC, Finch CA. Idiopathic hemochromatosis, an iron storage disease. Medicine 1955;34:381-430.
78. Porto G, da Silva BM, Vincente C, de Souza M. Idiopathic haemochromatosis in North Portugal: association with haplotype A3B7. J Clin Pathol 1989;42:667-668.
79. Powell LW, Summers KW, Board PG, Axelson E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects: implications for early diagnosis and prevention. Gastroenterology 1990;98:1625-1632.
80. Wiggers P, Dalhoj J, Kiaer H, Ring-Larsen H, Hyltoft Petersen P, Blaabjerg O, Horder M. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991;51:143-148.
81. Milman N. Hereditary haemochromatosis in Denmark 1950-1985. Dan Med Bull 1991;38:385-393.
82. Czink E, Gyodi EK, Nemet K, Hollan S. HLA antigens in Hungarian patients with idiopathic haemochromatosis. J Clin Pathol 1991;44:79-81.
83. Edwards CQ, Skolnick MG, Kushner JP. Coincidental nontransfusional iron overload and thalassemia minor: association with HLA-linked hemochromatosis. Blood 1981;58:844-848.
84. Kaikov Y, Wadsworth LD, Hassall E, Dimmick JE, Rogers PCJ. Primary hemochromatosis in children: report of three newly diagnosed cases and review of the pediatric literature. Pediatrics 1992;90:37-42.
85. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328: 1616-1620.
86. Milman N. Iron status markers in hereditary haemochromatosis: distinction between individuals being homozygous and heterozygous for the haemochromatosis allele. Eur J Haematol 1991;47:292-298.
87. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973;26:770-772.
88. Cook JD, Lipschitz DA, Miles LEM, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27:681-687.
89. Beamish MR, Walker R, Miller F, Worwood M, Jacobs A, Williams R, Corrigall A. Transferrin iron, chelatable iron and ferritin in idiopathic haemochromatosis. Br J Haematol 1974;27:219-228.
90. Thomson ABR, Brust R, Ali MAN, Mant MJ, Valberg LS. Iron deficiency in inflammatory bowel disease. Am J Dig Dis 1978;23:705-709.
91. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984;87:628-633.
92. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-113.
93. Lin E, Adams PC. Biochemical liver profile in hemochromatosis: a survey of 100 patients. J Clin Gastroenterol 1991;13:316-320.
94. Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971;1:100-103.
95. Brissot P, Bourel M, Herry D, Verger J-P, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981;80;557-565.
96. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 1982;27:909-916.
97. LeSage G, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall JT, Moore SB, Taswell HF, Gordon H. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983;84:1471-1477.
98. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis, Hepatology 1986;6:24-29.
99. Moyer TP, Baldus WP, Fairbansk VF et al. Unpublished.
100. Summers KM, Halliday JW, Powell LW. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 1990;12:20-25.
101. Olynyk J, Hall P, Sallie R, Reed W, Shilkin K, MacKinnon, M. Computerized measurement of iron in liver biopsies: a comparison with biochemical iron measurement. Hepatology 1990;12:26-30.
102. Bonkovsky HL, Slaker DP, Bills EB, Wolf DC. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990;99:1079-1091.
103. Sallie RW, Reed WD, Shilkin KB. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 1991;32:207-210.
104. Stark DD, Moseley ME, Bacon BR, Moss AA, Goldbert HI, Bass NM, James TL. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985;154:137-142.
105. Brown DW, Henkelman RM, Poon PY, Fisher MM. Nuclear magnetic resonance study of iron overload in liver tissue. Magn Reson Imaging 1985;3:275-282.
106. Gomon JM, Hoven G, Tamary H, Zandbach J et al. Hepatic iron overload: quantitative MR imaging. Radiology 1991;179:367-369.
107. Siegelman ES, Mitchell DG, Rubin R, Hann H-WL et al. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 1991;179:361-366.
108. Brittenham GM, Farrell DE, Harris JW et al. Magnetic susceptibility measurement of human iron stores. N Engl J Med 1982;307:1671-1675.
109. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M et al. Evaluation of computed tomography in the assessment of liver iron overload. Gastroenterology 1989;97:737-743.
110. Andersen PB, Birgegard G, Nyman R, Hemmingsson A. Magnetic resonance imaging in idiopathic hemochromatosis. Eur J Haematol 1991;47:174-178.
111. Housman JF, Chezmar JL, Nelson RC. Magnetic resonance imaging in hemochromatosis: extrahepatic iron deposition. Gastrointest Radiol 1989;14:59-60.
112. Chapman RWG, Williams G, Bydder G, Dick R, Sherlock S, Kreel L et al. Computed tomography for determining liver iron content in primary haemochromatosis. Br Med J 1980;280:440-442.
113. Bonkovsky HL, Weber RW, Aaron L. Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion. Am J Gastroenterol 1990;85:554-557.
114. Edwards CQ, Kelly TM, Ellwein G, Kushner JP. Thyroid disease in hemochromatosis: increased incidence of homozygous men. Arch Intern Med 1983;143:1890-1893.
115. Muench KH. Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med 1989;87:
116. Bullen JJ, Spalding PB, Ward CG, Gutteridge JMC. Hemochromatosis, iron, and septicemia caused by vibrio vulnificus. Arch Intern Med 1991;151:1606-1609.
117. Gambino R. Routine screening for iron status. Hosp Pract 1991;26(3):41-44.
118. Edwards CQ. Early detection of hereditary hemochromatosis. Editorial. Ann Intern Med 1984;101:707-708.
119. Simon M, Bourel M, Genetet B, Fauchet R, Edan G, Brissot P. Idiopathic hemochromatosis and iron overload in alcoholic liver disease: differentiation by HLA phenotype. Gastroenterology 1977;73:655-658.
120. Powell LW. The role of alcoholism in hepatic iron storage disease. Ann NY Acad Sci 1975;252:124-134.
121. Edwards CQ, Cartwright GE, Skolnick MH. Homozygosity for hemochromatosis: clinical manifestations. Ann Intern Med 1980;93:519-525.
122. de Bont B, Walker AC, Carter RF, Oldfield RK, Davidson GP. Idiopathic hemochromatosis presenting as acute hepatitis. J Pediatr 1987;110:431-434.
123. Stankoski JA, Roth JA, Gillin JS. Chronic active hepatitis and hepatic failure in the setting of idiopathic hemochromatosis. Am J Gastroenterol 1987;82:61-65.
124. Edwards CQ, Griffen LM, Kushner JP. Coincidental hemochromatosis and viral hepatitis. Am J Med Sci 1991;301:50-54.
125. di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-2113.
126. Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary hemochromatosis: analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982;78:196-207.
127. Miur AW, McLaren GD, Braun W, Askari A. Evidence for heterogeneity in hereditary hemochromatosis; evaluation of 174 persons in nine families. Am J Med 1984;76:806-814.
128. Borwein S, Ghent CN, Valberg LS. Diagnostic efficacy of screening tests for hereditary hemochromatosis. Can Med Assoc J 1984;131:895-901.
129. Bassett ML, Halliday JW, Bryant S, Dent O, Powell LW. Screening for hemochromatosis. Ann NY Acad Sci 1989;526:274-289.
130. Skikne BS, Cook JD. Screening test for iron overload. Am J Clin Nutr 1987;46:840-843.
131. Roberts PL, Johnson GF, Feld RD. Analytical factors influencing measurement of serum unsaturated iron binding capacity (UIBC) on a discrete analyzer. Abstract. Clin Chem 1988;34:1305.
132. Goodwin JF. Direct estimation of serum iron and unsaturated iron binding capacity in a single aliquot. Clin Biochem 1970;3:307-314.
133. Dlott D, Siegel M, Bersohn R. A proposed fluorimetric determination of unsaturated iron-binding capacity. Am J Clin Pathol 1975;64:217-224.
134. Buffone GJ, Lewis SA, Iosefsohn M, Hicks JM. Chemical and immunochemical measurement of total iron-binding capacity compared. Clin Chem 1978;24(10):1788-1791.
135. Beilby J, Olynyk J, Ching S, Prins A et al. Transferrin index: an alternative method for calculating the iron saturation of transferrin. Clin Chem 1992;38(10):2078-2081.
136. Crosby WH, O'Neil-Cutting MA. A small-dose iron tolerance test as an indicator of mild iron deficiency. J Am Med Assoc 1984;251:1986-1987.
137. CAP QAS. College of American Pathologists. Northfield, Ill.
138. CAP Chemistry Survey, C-A. College of American Pathologists. Northfield, Ill, 1991.
139. Personal communication. John Eckfeldt, MD, CAP Chemistry Resource Committee.
140. Gilbert RK. Accuracy of clinical laboratories studied by comparison with definitive methods. Am J Clin Pathol 1978;70:450-470.
141. Itano M. CAP comprehensive chemistry. Am J Clin Pathol 1978;70:516-522.
142. National Committee for Clinical Laboratory Standards. Determination of serum iron and total iron-binding capacity; proposed standard. NCCLS publication H17-P. Villanova, Pa.: NCCLS, 1990.
143. Tietz NW, Rinker AD, Morrison SR. When is a serum iron really a serum iron? The status of serum iron measurements. Clin Chem 1994;40(4):546-551.
144. Eckfeldt JH, Witte DL. Serum iron: Would analytical improvement enhance patient outcome? Clin Chem 1994;40(4):505-507.
145. Friedman RB, Young DS. Effects of disease on clinical laboratory tests. Washington, DC: AACC Press, 1989.
146. Pilon VA, Howanitz PJ, Howanitz JH, Domres N. Day-to-day variation in serum ferritin concentration in healthy subjects. Clin Chem 1981;27(10):78-82.
147. Werkman HP, Trijbels JMF, Schretlen ED. The 'short-term' iron rhythm. Clin Chim Acta 1974;53:65-68.
148. Dawkins S, Cavill I, Ricketts C, Worwood M. Variability of serum ferritin concentration in normal subjects. Clin Lab Haematol 1979;1:41-46.
149. Wiltink WF, Kruithof J, Mol C, Bos G, van Eijk HG. Diurnal and nocturnal variations of the serum iron in normal subjects. Clin Chim Acta 1973;49:99-104.
150. Bowie EJW, Tauxe WN, Sjoberg WE, Yamaguchi MY. Daily variation in the concentration of iron in serum. Am J Clin Pathol 1963;40(5):491-494.
151. Statland BE, Winkel P. Relationship of day-to-day variation of serum iron concentrations to iron-binding capacity in healthy young women. Am J Clin Pathol 1977;67:84-90.
152. Costongs GMPJ, Janson PCW, Bas BM, Hermans J, van Wersch JWJ, Brombacher PJ. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 1985;23:7-16.
153. Hamilton LD, Gubler CJ, Cartwright GE, Wintrobe MM. Diurnal variation in the plasma iron level of man. Proc Soc Exp Biol Med 1950;75:65-68.
154. Wands JR et al. Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med 1976;294:302-305.
155. Witte DL, Angstadt DS, VanNess S. What is the appropriate reference range for serum ferritin? Clin Chem 1994;40(6):1017.
156. Edwards CQio, Carroll M, Bray P, Cartwright GE. Hereditary hemochromatosis; diagnosis in siblings and children. N Engl J Med 1977;297:7-13.
157. Olsson KS, Eriksson K, Ritter B, Heedman PA. Screening for iron overload using transferrin saturation. Acta Med Scand 1984;215:105-112.
158. Chuong JJH. A screening primer: basic principles, criteria, and pitfalls of screening with comments on colorectal carcinoma. J Clin Gastroenterol 1983;5:229-233.
159. Phatak PD, Guzman G, Woll J, Robeson A, Phelps CE. Cost-effectiveness of screening for hemochromatosis. Arch Int Med 1994;154:769-776.
160. Edwards CQ, Griffen LM, Kushner JP. The morbidity of hemochromatosis among clinically unselected homozygotes: preliminary report. In: Chaim Herskho, eds. Iron research, (in press).
161. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96: 102-109.
162. Winkelman JW. Less utilization of the clinical laboratory produces disproportionately small true cost reductions. Hum Pathol 1984;15(6):499-501.
163. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994; (in press).
164. Balan V, Baldus WP, Fairbanks VF et al. Screening for hemochromatosis: a cost effectiveness study based on 12258 patients. Gastroenterology 1994;107(2):453-459.
165. Witte DL. Unsaturated iron binding capacity identifies iron overload in ambulatory individuals. Clin Chem 1995;41(6)S145-146.
166. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clin epidemiology. A basic science for clinical medicine. Boston: Little Brown, 1991.
167. Eddy DM. Medicine, money, and mathematics. Am Coll Surg Bull 1992;77(6):36-49.
168. Cazzola M, Dezza L, Bergamaschi G et al. Biologic and clinical significance of red cell ferritin. Blood 1983;62(5):1078-1087.
169. Van der Weyden MB, Fong H, Salem HH, Batey RG, Dudley FJ. Erythocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload. Scand J Haematol 1984;33:373-377.
170. Cruickshank MK, Ninness J, Curtis A et al. Usefulness of erythrocyte ferritin analysis in hereditary hemochromatosis. Can Med Assoc J 1987;136:1259-1263.
171. Fairbanks VF. Laboratory testing for iron status. Hosp Pract 1991;26(3):17-24.
172. Wheby MS. Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. Blood 1980;56:138-140.
173. Witte DL. Can serum ferritin be effectively interpreted in the presence of the acute-phase response? Clin Chem 1991;37(4):484-485.
174. Heisto H, Foss OP. Iron deficiency and treatment in blood donors studied by the iron adsorption test. Scand J Clin Lab Invest 1958;10:102-107.
175. di Biceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-2113.
176. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: Mac Sween RNM, Anthony PP, Scheuer PJ, eds. Pathology of the liver. 2nd ed. London: Churchill Livingstone, 1987:181-201.
177. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bact 1962;84:53-63.
178. Deugnier YM, Loreal O, Turlin B et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-2059.
179. Deugnier YM, Turlin B, Powell LW, Summers KM, Moirand R, Fletcher L, Loreal O, Brissot P, Halliday JW. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 1993;17:30-34.
180. Scheuer PJ. Disturbances of copper and iron metabolism. In: Liver biopsy interpretation. 2nd ed. Baltimore: Williams and Wilkins, 1973:121-127.
181. Loreal O, Deugnier YM, Moirand R, Lauvin L, Guyader D, Jouanolle H, Turlin B, Lescoat G, Brissot P. Liver fibrosis in genetic hemochromatosis. J Hepatol 1992;16: 122-127.
182. Suda K. Hemosiderin deposition in the pancreas. Arch Pathol Lab Med 1985;109: 996-999.
183. Olsson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987;10:1239-1243.
184. Olsson LJ, Edwards WD, Holmes DR, Miller FA, Nordstrom LA, Baldus WP. Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases. J Am Coll Cardiol 1989;13:116-120.
185. Astaldi G, Meardi G, Lisino T. The iron content of jejunal mucosa obtained by Crosby's biopsy in hemochromatosis and hemosiderosis. Blood 1966;28:70-82.
186. MacDonald RA, Mallory GK. Hemochromatosis and hemosiderosis: study of 211 autopsied cases. Arch Intern Med 1959;105:686-700.
187. Scheuer PJ. In: Liver biopsy interpretation. Baltimore: Williams and Wilkins Co., 1973.
188. Piccinino F, Sagnelli E, Pasquale G et al. Complications following percutaneous biopsy of the liver. J Hepatol 1986;2:165-173.
189. McGill DB, Rakela Z, Zinsmeister AR et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-1400.
190. Mahal AS, Knauer M, Gregory PB. Bleeding after liver biopsy. West J Med 1985;134:11-14.
191. Terry R. Risks of needle biopsy of the liver. Br Med J 1952;1:1102.
192. Davis WD, Arrowsmith WR. The effect of repeated phlebotomies in hemochromatosis; report of three cases. J Lab Clin Med 1952;39:526-532.
193. Crosby WH. Treatment of haemochromatosis by energetic phlebotomy; one patient's response to the letting of 55 litres of blood in 11 months. Br J Haematol 1958;4:82-88.
194. Bothwell TH et al. Iron metabolism in man. Oxford: Blackwell Scientific Publications, 1979:136-139.
195. Finch CA et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657-663.
196. Wohler F. The treatment of haemochromatosis with desferrioxamine. Acta Haematol 1963;30:65-87.
197. Schwartz E, Benz EJ. Hemosiderosis and chelation therapy. In: Hoffman R et al, eds. Hematology basic principles and practice. New York: Churchill Livingston, 1991; 381-382.
198. Crosby WH et al. Hemochromatosis (iron storage disease); clinical grand rounds. J Am Med Assoc 1974;228:743-752.
199. Cook JD. Clinical evaluation of iron deficiency. Semin Hematol 1982;19:6-18.
200. Crosby WH. Personal observation.
201. Williams R et al. Venesection therapy in idiopathic hemochromatosis: an analysis of 40 treated and 18 untreated patients. Am J Med 1969;28:1-18.
202. Stremmel W et al. Abnormalities in estrogen, androgen and insulin metabolism in idiopathic hemochromatosis. In: Weintraub LR et al. eds. Hemochromatosis: Proceedings of the First International Conference. Ann NY Acad Sci 1989;526:209-223.